[Evidence for the benefits of ACE inhibitors and AII antagonists in slowing progressive renal failure in diabetes].
Suzuki
Hiromichi
H
Department of Nephrology, Saitama Medical School.
D017311:Amlodipine / Q000627:therapeutic use; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use; D002216:Captopril / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D018450:Disease Progression; D006801:Humans; D000077405:Irbesartan; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000517:prevention & control*; D019808:Losartan / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use; D016896:Treatment Outcome
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001713:Biphenyl Compounds; D013777:Tetrazoles; D017311:Amlodipine; D002216:Captopril; D000077405:Irbesartan; D019808:Losartan